...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Chinese Takeovers

SF - None. We spoke very briefly at the AGM. I did notice that Dr Wong is the Chief Science Officer at RVX. My best guess is that he understands his skill sets and puts them to use where they are best suited.

tada

Share
New Message
Please login to post a reply